New Haven, Connecticut
United States
23
2025-08-07
The entities that hold a legal rights for patent applications filed by inventor Ring Aaron Michael:
Aaron Michael Ring from New Haven, US has applied for patents for these inventions. The list has both pending applications and granted patents:
ENGRAFTMENT OF STEM CELLS WITH A COMBINATION OF AN AGENT THAT TARGETS STEM CELLS AND MODULATION OF IMMUNOREGULATORY SIGNALING
#2 | 2025-07-10HIGH AFFINITY SIRP-ALPHA REAGENTS AND METHODS OF USING
#3 | 2024-05-30HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
#4 | 2022-11-03Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
#5 | 2022-03-03High affinity SIRP-alpha reagents and methods of using
#6 | 2021-04-08Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
#7 | 2021-02-11High affinity PD-1 agents and methods of use
#8 | 2020-08-20Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPalpha antibody therapy
#9 | 2020-07-23Compositions comprising G protein-coupled receptors maintained in a conformationally selective manner by a modulator
#10 | 2020-04-30Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
#11 | 2019-08-08Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
#12 | 2019-07-18Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells
#13 | 2018-11-08Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies
#14 | 2018-09-06Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
#15 | 2018-07-12High affinity SIRP-alpha reagents and methods of using
#16 | 2018-06-21SIRP-α agonist antibody
#17 | 2018-05-31BTN3A ECTODOMAIN PROTEINS AND METHODS OF USE
#18 | 2018-05-10High affinity CD47 analogs
#19 | 2018-04-05Complexes comprising transmembrane receptors and antibodies that bind the receptors in a conformationally selective manner
#20 | 2018-02-08Compositions and methods for expressing polypeptides on the surface of cells
#21 | 2018-02-08Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPα antibody therapy
#22 | 2017-08-17High affinity PD-1 agents and methods of use
#23 | 2017-08-10Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
1950966 ⎘